Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target. [electronic resource]
- American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2013
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Video-Audio Media
1548-8756
10.14694/EdBook_AM.2013.33.e295 doi
Animals Antineoplastic Agents--therapeutic use Biomarkers, Tumor--genetics Cell Transformation, Neoplastic--genetics Drug Design Epigenesis, Genetic--drug effects Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Humans Lung Neoplasms--drug therapy Molecular Targeted Therapy Phenotype